Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

Obefazimod, Abivax’s lead investigational drug candidate, is an orally administered small ... Marchés Financiers pursuant to its legal obligations including its universal registration document ...

A Bedford man is facing multiple charges after a routine traffic stop led to the discovery of methamphetamine, a firearm, and ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system?the ...

SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Active clinical trial sites now enrolling patients d ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

European Union regulators hit Facebook parent Meta with a fine of nearly 800 million euros on Thursday for what it calls ...

The global healthcare IT market is projected to reach USD 834.35 billion by 2029 from USD 420.23 billion in 2024, at a high ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

This regular publication from DLA Piper focuses on helping banking and financial services clients navigate the ever-changing regulatory landscape. In ...